Originally aired: February 2, 2023
Time: 9:30 am PT, 12:30 pm ET, 18:30 CET

Science has come quite a long way since the early days of genetic testing over 60 years ago. Our greater understanding of human genetics combined with advanced genomic technologies has allowed researchers to scrutinize numerous genes at once to create genetic profiles that can be scanned for DNA alterations. This comprehensive genomic profiling (CGP) is quickly becoming an invaluable diagnostic tool for oncologists treating various cancer forms. In addition, CGP can provide more significant insights into the drivers of tumor mutagenesis, informing researchers when developing new therapies and physicians when selecting the appropriate treatment course.

In this Inside Precision Medicine Webinar, our distinguished guest, Dr. Sandip Patel, discussed the importance of comprehensive genomic profiling in lung cancer and other solid tumors to direct optimal standard of care for cancer patients. Dr. Robin Thomas presented data from a study evaluating the AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit.

A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelists.

Roche logo

Sandip Patel, MD
Associate Professor of Medicine
University of California, San Diego
Robin Thomas, PhD
Scientific Partner, Sequencing
Medical and Scientific Affairs
Roche Diagnostics Corporation


Also of Interest